ESC Premium Access

Panel discussion / Q&A - Advancing approaches to dyslipidemia management: optimizing risk reduction in primary and secondary prevention populations.

Congress Presentation

About the speakers

Doctor C Michael Gibson

Harvard Medical School, Boston (United States of America)
14 presentations
1 follower

Professor Wolfgang Koenig

German Heart Center of Munich, Munich (Germany)
24 presentations
0 follower

Professor J Wouter Jukema

Leiden University Medical Center, Leiden (Netherlands (The))
20 presentations
0 follower

3 more presentations in this session

Welcome and introductions - Advancing approaches to dyslipidemia management: optimizing risk reduction in primary and secondary prevention populations.

Speaker: Doctor C. Gibson (Boston, US)

Thumbnail

Beyond statins: understanding unmet need across the CV risk continuum.

Speaker: Professor W. Koenig (Munich, DE)

Thumbnail

Current challenges in CV risk reduction for high-risk primary and secondary prevention populations.

Speaker: Professor J. Jukema (Leiden, NL) Doctor C. Gibson (Boston, US)

Thumbnail

Access the full session

Advancing approaches to dyslipidemia management: optimizing risk reduction in primary and secondary prevention populations

Speakers: Doctor C. Gibson, Professor W. Koenig, Professor J. Jukema, Doctor C. Gibson, Professor W. Koenig...
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb